Search results for "P21"

showing 10 items of 131 documents

Miten käsitteellistää ammatillista toimijuutta työssä?

2014

Artikkelissa tarkastellaan, miten toimijuus on ymmärretty monitieteisessä keskustelussa. Lisäksi pohditaan, miten ammatillista toimijuutta työssä tulisi käsitteellistää. peerReviewed

monitieteisyys [http://www.yso.fi/onto/yso/p11916]sosiokulttuuriset tekijät [http://www.yso.fi/onto/yso/p21870]monitieteisyyskäsitteenmuodostustyöelämä [http://www.yso.fi/onto/yso/p16262]General MedicineGeneral Chemistryammatillinen toimijuustoimijuuskäsityksettoimijuus [http://www.yso.fi/onto/yso/p2335]työ [http://www.yso.fi/onto/yso/p1810]käsitteellistäminenArtikkelittyöelämäontologia (filosofia) [http://www.yso.fi/onto/yso/p1055]
researchProduct

Analysis of the effects of K-RasG12V and K-RasG13D on the cell cycle

2012

p21 Ras is small protein with GTPase activity that regulates proliferation, differentiation and apoptosis in all cell types. The three major isoforms of Ras (H-, K- and N-Ras) differing only for the last 24 aminoacids have different post-translational modifications that lead to localization in diverse plasma membrane microdomains and downstream activation of alternative pathways of signal transduction. This might explain, at least in part, the different biological effects of the Ras isoforms in the cells. Ras mutations are a common event in several tumours and in almost all cases they are point mutations in codons 12 or 13, and rarely in codon 61. These mutations lead to a constitutively ac…

p21 RAS
researchProduct

Differential effects of Ha-RasG12V, Ki-RasG12V and Ki-RasG13D on cell proliferation

2012

Although differing only for the last 24 aminoacids, the three major isoforms of p21 Ras (Ha-, Ki- and N –Ras) can trigger alternative pathways of signal transduction, at least in part as a consequence of different post-translational modifications and subcellular localization. Ras mutations are a common event in tumorigenesis. In colorectal carcinomas (CRCs) the mutations affect almost exclusively Ki-Ras, while Ha-Ras mutations are mostly found in bladder carcinomas and N-Ras mutations in leukemia cells. In almost all cases, the genetic alteration is a point mutation in codons 12 or 13, and less frequently in codon 61. By affecting the GTPase activity of the protein, they always lead to a co…

p21 RAS
researchProduct

Analysis of the effects of an oncogenic stress on the cell cycle in human tumoral cells

2012

Although differing only for the last 24 aminoacids, the three major isoforms of p21 Ras (Ha-, Ki- and N –Ras) can trigger alternative pathways of signal transduction, at least in part as a consequence of different post-translational modifications and subcellular localization. Ras mutations are a common event in tumorigenesis. In colorectal carcinomas (CRCs) the mutations affect almost exclusively Ki-Ras, while Ha-Ras mutations are mostly found in bladder carcinomas and N-Ras mutations in leukemia cells. In almost all cases, the genetic alteration is a point mutation in codons 12 or 13, and less frequently in codon 61. By affecting the GTPase activity of the protein, they always lead to a co…

p21 RAS
researchProduct

Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations

2004

Analysis of the genetic status of Ki-ras and p53 in primary colorectal carcinomas and matched colorectal liver metastasis from 30 patients reveals an overall heterogeneity both within and between the two tumoral tissues. Both genes were found mutated with a similar frequency in both tissues; however, identical mutations in primary tumor and matched metastasis were found less frequently in the case of the Ki-ras than the p53 gene. Only in three cases the same p53 and Ki-ras mutations found in the primary tumor were found also in the metastasis. In several metastatic specimens the DNA bearing a mutation detected also in the primary tumor appears significantly less abundant than the wild-type …

p53Colorectal cancerDNA Mutational AnalysisStatistics as TopicBiophysicsKi-raBiologyOncogene Protein p21(ras)medicine.disease_causeBiochemistryMetastasisMetastasischemistry.chemical_compoundSequence Homology Nucleic AcidmedicineHumansMolecular BiologyGeneRegulation of gene expressionMutationGene Expression ProfilingCarcinomaLiver NeoplasmsCell BiologySequence Analysis DNAmedicine.diseasePrimary tumorGene expression profilingGene Expression Regulation NeoplasticColorectal carcinomaGenes raschemistryMutationCancer researchTumor Suppressor Protein p53Colorectal NeoplasmsDNA
researchProduct

Association between socioeconomic factors and origin of hospital referrals among patients with oral cancer.

2022

The Brazilian Unified Health System (SUS) is responsible for offering free assistance to more than 100 million Brazilians, including treatment of oral cancer lesions. Considering that the Brazilian public system aids the most vulnerable population, this study analyzed whether the origin of hospital referrals of patients with oral cancer is associated with socioeconomic factors. A cross-sectional study was carried out from cancer hospital records of the National Cancer Institute (RHC-INCA), considering the primary locations (C00 to C06) diagnosed between 2016 and 2019. Data on gender, skin color (white and non-white), education (no schooling, incomplete or complete elementary education; high…

p53malignant transformationp21bcl-2biomarkerspcnaoral lichen planusCross-Sectional StudiesOtorhinolaryngologySocioeconomic FactorsimmunohistochemistryHumansSurgeryMouth NeoplasmsGeneral DentistryReferral and ConsultationUNESCO:CIENCIAS MÉDICASBrazilMedicina oral, patologia oral y cirugia bucal
researchProduct

ATTIVITÀ ANTIPROLIFERATIVA DI UN DERIVATO POLICICLICO CON STRUTTURA COMPLESSA

2014

Un nuovo derivato policiclico glicosilato è stato ottenuto partendo dal derivato policiclico iodurato, utilizzando la reazione di Sonogashira.Il composto glicosilato saggiato presso l’NCI è risultato attivo su tutte le 60 linee cellulari tumorali del panel, risultando più attivo degli altri composti policiclici precedentemente saggiati. Il composto induce l’arresto del ciclo cellulare in fase G2/M nella linea cellulare MDA-MB231, fa diminuire i livelli di ciclina B1e Cdc-2 mentre produce un aumento dell’inibitore p21WAF1, una chinasi ciclino-dipendente.

policicli antitumorali ciclina B1e Cdc-2 p21WAF1
researchProduct

Rac1 and PAK1 are upstream of IKK-ε and TBK-1 in the viral activation of interferon regulatory factor-3

2004

The anti-viral type I interferon (IFN) response is initiated by the immediate induction of IFN beta, which is mainly controlled by the IFN-regulatory factor-3 (IRF-3). The signaling pathways mediating viral IRF-3 activation are only poorly defined. We show that the Rho GTPase Rac1 is activated upon virus infection and controls IRF-3 phosphorylation and activity. Inhibition of Rac1 leads to reduced IFN beta promoter activity and to enhanced virus production. As a downstream mediator of Rac signaling towards IRF-3, we have identified the kinase p21-activated kinase (PAK1). Furthermore, both Rac1 and PAK1 regulate the recently described IRF-3 activators, I kappa B kinase- and TANK-binding kina…

rac1 GTP-Binding ProteinTranscription GeneticBiophysicsIκB kinaseProtein Serine-Threonine KinasesSignal transductionBiologyVirus ReplicationBiochemistryCell LineDogsPAK1Structural BiologyInterferonGeneticsmedicineAnimalsHumansPhosphorylationPromoter Regions Geneticp21-activated kinasesMolecular BiologyRNA Double-StrandedKinaseRho GTPaseI-Kappa-B KinaseNuclear ProteinsInterferon-betaCell BiologyCREB-Binding ProteinI-kappa B KinaseDNA-Binding ProteinsEnzyme Activationp21-Activated KinasesInfluenza A virusViral infectionAnti-viral responseTrans-ActivatorsCancer researchInterferon Regulatory Factor-3Transcription factorSignal transductionDimerizationTranscription FactorsInterferon regulatory factorsmedicine.drugFEBS Letters
researchProduct

Rakenteen ja kokemuksen komplementaarisuus laadullisen aineiston tulkinnassa ja analyysissa

2019

Artikkelissa käsitellään yhteiskuntatieteiden tutkimusmetodologiassa esiintyvää, yhteiskunnallishistoriallisten rakenteiden ja yksilön kokemusten välistä rakennetta. Se kiinnittyy hallinnan ja ideologioiden kriittisen tutkimuksen metodologiaan. Ongelmakentän tarkentamiseksi analysoidaan kahden tutkimusperinteen tarjoamia välineitä rakenteen ja kokemuksen yhdistämiseen tutkimusmetodiikassa. Perinteet ovat hallinnan analytiikka ja psykoanalyyttinen, yksilöllisiä kokemuksia painottava tutkimustraditio. Erityisesti tarkastellaan mahdollisuutta tuottaa analyysia, jossa otetaan huomioon sekä yhteiskunnan rakenteet että yksilön kokemus. Empiirisenä esimerkkinä käytetään vuonna 2015 valmistunutta t…

rakennehallintatutkimusmenetelmät [http://www.yso.fi/onto/yso/p415]työelämä [http://www.yso.fi/onto/yso/p16262]ideologiat [http://www.yso.fi/onto/yso/p216]psykodynamiikkaGeneral MedicineGeneral Chemistryhallinta [http://www.yso.fi/onto/yso/p506]psykoanalyysi [http://www.yso.fi/onto/yso/p5870]kokemuksetanalyysikokemukset [http://www.yso.fi/onto/yso/p3209]tutkimusmenetelmätpsykoanalyysiArtikkelittyöelämärakenne [http://www.yso.fi/onto/yso/p7302]analyysi [http://www.yso.fi/onto/yso/p6851]ideologiatpsykodynamiikka [http://www.yso.fi/onto/yso/p13202]Aikuiskasvatus
researchProduct

Indagini genetiche e trattamenti prenatali in utero della Sindrome Adreno Genitale (SAG) in una Coorte Siciliana.

2008

La deficienza dell'enzima 21 idrossilasi (21OHD) è la causa più comune di sindrome adrenogenitale (SAG). Il gene implicato è il CYP21 (6p21.3). La SAG è un problema clinico-sociale in quanto nel 95% dei casi genera l'iperandrogenismo dei neonati di sesso femminile. Il trattamento più effettuato in corso di virilizzazzione dei genitali femminili esterni è di tipo chirurgico (genitoplastica). Il trattamento prenatale in utero è una alternativa medica con il fine di compensare il difetto enzimatico e prevenire l'eccesso di androgeni in corso di morfogenesi fetale. Un nuovo protocollo diagnostico-terapeutico prenatale è stato sviluppato sulla base di una terapia precoce (alla 5° WG) con Desamet…

sindrome adrenogenitale Il gene CYP21 trattamento prenatale in utero.Settore MED/38 - Pediatria Generale E Specialistica
researchProduct